Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: A population-based analysis of elderly patients

被引:78
作者
Steyerberg, EW
Earle, CC
Neville, BA
Weeks, JC
机构
[1] Erasmus MC, Dept Publ Hlth, Ctr Clin Decis Sci, NL-3000 DR Rotterdam, Netherlands
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
关键词
D O I
10.1200/JCO.2005.05.169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose We investigated racial disparities in access to surgical evaluation, receipt of surgery, and survival among elderly patients with locoregional esophageal cancer. Methods We selected 2,946 white patients and 367 black patients who were older than 65 years and had clinically locoregional esophageal cancer in the Surveillance, Epidemiology, and End Results (SEER) registry (1991 to 1999). Treatment and outcome data were obtained from the linked SEER-Medicare databases. We used logistic regression analysis to estimate odds ratios (ORs) for being seen by a surgeon and for Undergoing surgery. Cox proportional hazards analyses were performed to estimate hazard ratios (HRs) for survival adjusted for medical, nonmedical, and treatment characteristics. Results The rate of surgery for black patients was half that of white patients (25% v 46%; OR, 0.38; P < .001), which was caused by both a lower rate of seeing a surgeon (70% v 78%; OR, 0.66; P < .001) and a lower rate of surgery once seen (35% v 59%; OR, 0.38; P < .001). These racial disparities were only partly explained by differences in patient and cancer characteristics, and not by nonmedical factors, such as socioeconomic status. The 2-year survival rate was lower for black patients (18% v 25%; HR, 1.18; P = .004), but this racial difference disappeared when corrected for treatment received (adjusted HR, 1.02; P = .80). Conclusion Underuse of potentially curative surgery is an important potential explanation for the poorer survival of black patients with locoregional esophageal cancer. Barriers to surgical evaluation and treatment need to be reduced, whether related to patient or healthcare system factors. (C) 2005 by American Society of Clinical Oncology.
引用
收藏
页码:510 / 517
页数:8
相关论文
共 43 条
[1]   Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort [J].
Ayanian, JZ ;
Zaslavsky, AM ;
Fuchs, CS ;
Guadagnoli, E ;
Creech, CM ;
Cress, RD ;
O'Connor, LC ;
West, DW ;
Allen, ME ;
Wolf, RE ;
Wright, WE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) :1293-1300
[2]   Survival of blacks and whites after a cancer diagnosis [J].
Bach, PB ;
Schrag, D ;
Brawley, OW ;
Galaznik, A ;
Yakren, S ;
Begg, CB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (16) :2106-2113
[3]   Racial differences in the treatment of early-stage lung cancer [J].
Bach, PB ;
Cramer, LD ;
Warren, JL ;
Begg, CB .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (16) :1198-1205
[4]  
Bach PB, 2002, MED CARE, V40, P19
[5]  
Bartels H, 1998, BRIT J SURG, V85, P840
[6]   Race and trust in the health care system [J].
Boulware, LE ;
Cooper, LA ;
Ratner, LE ;
LaVeist, TA ;
Powe, NR .
PUBLIC HEALTH REPORTS, 2003, 118 (04) :358-365
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of the Netherlands in 1993-1996 [J].
Coebergh, JWW ;
Janssen-Heijnen, MLG ;
Post, PN ;
Razenberg, PPA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (12) :1131-1136
[9]  
Collins T.C., 2002, MED CARE, V40, DOI [DOI 10.1097/00005650-200201001-00004, 10.1097/00005650-200201001-00004]
[10]  
Cooper GS, 2002, MED CARE, V40, P43